Clinical Study of Laghvashan Langhan-Pachan With Shunthi Churna In Amlapitta

A Compilation Of Ashtang Hridayokta Ama Chikitsa Siddhant And Randomized Controlled Trial Of The Efficacy Of Laghvashan Langhan-Pachan With Shunthi Churna In Amlapitta. - ELPS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/028940

Enrollment

Registered

2020-11-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: Langhan-Pachan with Shunthi churna: Dosage-Shunthi churna 5gram in Samankala with Laghvashan Duration of therapy-7days Anupana-Koshna jala Control Intervention1: Shunthi Churna-5gram: D

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria of Amlapitta that is with 19 grades out of 37 grades of symptoms will be diagnosed as Amlapitta

Exclusion criteria

Exclusion criteria: Patients suffering from other systemic diseases like Parinamshool, Food poisoning, Hypertension, Diabetes, Mental disorders Patients who are steroid/any other dependent Pregnant and lactating woman

Design outcomes

Primary

Measure	Time frame
To study the relief found in signs and symptoms of Amlapitta due to AmapachanTimepoint: 7days	—

Secondary

Measure	Time frame
To study the process and duration of Laghvashan Langhan-Pachan in Saam diseaseTimepoint: 7days	—

Countries

India

Contacts

Public ContactVd Chhaya D Manjarmkar

Government Ayurveda College Nanded

chhayadingu@yahoo.in9423438655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026